Page 11 - Aspro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Spero Therapeutics (NASDAQ:SPRO – Get Rating) will post its quarterly earnings results after the market closes on Thursday, March 31st. Analysts expect Spero Therapeutics to post earnings of ($0.81) per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link. Shares of Spero Therapeutics stock […]

Ankit mahadeviaWells fargo companyZacks investment researchSpero therapeutics company profile get ratingSpero therapeutics incAquilo capital management llcCitigroup incBarclays plcSpero therapeuticsGet ratingInvestment researchAquilo capital managementTherapeutics company profileNasdaq spro